We are a biotechnology Spin-off of the Autonomous University of Madrid (UAM),Our mission is to improve the health of people affected by chronic diseases. Our current priority is to curb liver injury that arises in patients with severe fatty liver disease.We are working on the pharmacological regulation of a protein that exerts multiple lines of protection against oxidative, inflammatory and metabolic stress. This protein is the transcription factor NRF2 (Nuclear factor erythroid 2 – related factor 2).
.png)
